Article: Astrogenetix Teams with NASA to Use Microgravity to Develop New Medicines.

Along with supply and equipment cargo bound for the International Space Station, Space Shuttle Discovery STS-128 will carry an additional scientific payload being conducted by Austin-based Astrogenetix, the first commercial space company to use microgravity to discover the foundation of new medicines.

In a release, the group noted that specifically, research will be conducted on Staphylococcus aureus and Salmonella microbes in search of a potential target for a therapeutic agent or vaccine candidate. These bacterial microbes are known to cause hundreds of thousands of medically diagnosed infections every year around the world.

Astrogenetix has worked ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!